Science 37 Holdings Inc. is a leading technology company that is redefining how clinical trials are conducted. Their innovative platform enables virtual, decentralized trials, making participation easier and more accessible for patients. With their advanced technology and network of experienced researchers, Science 37 is revolutionizing the way research is done, improving patient outcomes and expediting the drug development process.
